Axite has secured €250,000 in Takeoff 2 early-stage funding, a significant step forward in their journey of innovation and growth. Meanwhile, 1NA has been honored with the prestigious 2025 CES Innovation Award, recognizing their outstanding contributions to technology and health.
These milestones reflect the spirit of ambition and innovation that defines our Leiden Bio Science Park community. Congratulations to both teams—here’s to an exciting future ahead!.
MIMETAS’ unique organ-on-a-chip and human tissue models complement Bruker’s multiomics, NMR, spatial biology and preclinical imaging solutions LEIDEN, The Netherlands–(BUSINESS WIRE)–Bruker Corporation (Nasdaq: BRKR) today announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue…
